Citadel Advisors’s Tiziana Life Sciences TLSA Stock Holding History

Citadel Advisors’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$41.1K	Buy	+35,094	New	+$49.7K	﹤0.01%	12479
2025 Q3	–	Sell	-198,990	Closed	-$314K	–	14118
2025 Q2	$314K	Buy	+198,990	New	+$266K	﹤0.01%	9706
2024 Q4	–	Sell	-104,291	Closed	-$100K	–	15395
2024 Q3	$100K	Buy	+104,291	New	+$105K	﹤0.01%	11115
2022 Q3	–	Sell	-49,535	Closed	-$37K	–	13609
2022 Q2	$37K	Buy	49,535 +35,562	+255%	+$30.6K	﹤0.01%	12114
2022 Q1	$15K	Buy	+13,973	New	+$12.4K	﹤0.01%	13316
2021 Q2	–	Sell	-34,687	Closed	-$96K	–	14436
2021 Q1	$96K	Buy	+34,687	New	+$115K	﹤0.01%	12505
2020 Q4	–	Sell	-36,924	Closed	-$117K	–	11522
2020 Q3	$124K	Buy	+36,924	New	+$144K	﹤0.01%	9141
2020 Q1	–	Sell	-26,140	Closed	-$28K	–	10179
2019 Q4	$28K	Buy	+26,140	New	+$28.8K	﹤0.01%	8885
2019 Q2	–	Sell	-65,924	Closed	-$80K	–	9855
2019 Q1	$80K	Buy	+65,924	New	+$81.5K	﹤0.01%	8639

Other funds holding TLSA

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return

Citadel Advisors's TLSA Position: Q1 2026 in Review

Citadel Advisors opened a new position in Tiziana Life Sciences (TLSA) in Q1 2026: 35,094 shares worth $41.1K. The stake represents ﹤0.01% of the portfolio and ranks #12479 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in TLSA as recently as Q2 2025.

Citadel Advisors first reported a position in TLSA in Q1 2019 and has held it in 9 quarters since. The position peaked at $314K in Q2 2025. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2026.

Citadel Advisors held 35,094 shares of Tiziana Life Sciences worth $41.1K as of Q1 2026.
Tiziana Life Sciences was a new Citadel Advisors position in Q1 2026.
Tiziana Life Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12479 holding.
Citadel Advisors first reported a position in Tiziana Life Sciences in Q1 2019 and has held it in 9 quarters since.
Citadel Advisors's Tiziana Life Sciences position peaked at $314K in Q2 2025.
32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.